Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-22-061708
Filing Date
2022-12-16
Accepted
2022-12-16 17:05:47
Documents
1
Period of Report
2022-12-14

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 25460
  Complete submission text file 0001209191-22-061708.txt   26830
Mailing Address 890 WINTER STREET SUITE 320 WALTHAM MA 02451
Business Address
Booth Bruce (Reporting) CIK: 0001451612 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39460 | Film No.: 221468765

Mailing Address 200 ARSENAL YARDS BLVD., SUITE 230 WATERTOWN MA 02472
Business Address 200 ARSENAL YARDS BLVD., SUITE 230 WATERTOWN MA 02472 857-285-5314
Kymera Therapeutics, Inc. (Issuer) CIK: 0001815442 (see all company filings)

EIN.: 812992166 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)